BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 18612221)

  • 1. Alpha-fetoprotein, stem cells and cancer: how study of the production of alpha-fetoprotein during chemical hepatocarcinogenesis led to reaffirmation of the stem cell theory of cancer.
    Sell S
    Tumour Biol; 2008; 29(3):161-80. PubMed ID: 18612221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K/AKT signal pathway.
    Zhu M; Li W; Lu Y; Dong X; Lin B; Chen Y; Zhang X; Guo J; Li M
    Int J Cancer; 2017 Mar; 140(6):1346-1355. PubMed ID: 27925189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell origin of cancer and differentiation therapy.
    Sell S
    Crit Rev Oncol Hematol; 2004 Jul; 51(1):1-28. PubMed ID: 15207251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular origin of cancer: dedifferentiation or stem cell maturation arrest?
    Sell S
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):15-26. PubMed ID: 7516873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver cancer stem cells.
    Sell S; Leffert HL
    J Clin Oncol; 2008 Jun; 26(17):2800-5. PubMed ID: 18539957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers.
    Sell S; Pierce GB
    Lab Invest; 1994 Jan; 70(1):6-22. PubMed ID: 8302019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
    Terris B; Cavard C; Perret C
    J Hepatol; 2010 Feb; 52(2):280-1. PubMed ID: 20006402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma.
    Zheng Y; Zhu M; Li M
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2439-2446. PubMed ID: 32725355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of stem cells in normal liver and cancer.
    Lau CK; Yang ZF; Fan ST
    Anticancer Agents Med Chem; 2011 Jul; 11(6):522-8. PubMed ID: 21554200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver stem cells: implications for hepatocarcinogenesis.
    Alison MR
    Stem Cell Rev; 2005; 1(3):253-60. PubMed ID: 17142862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
    Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer stem cells and hepatocellular carcinoma.
    Yao Z; Mishra L
    Cancer Biol Ther; 2009 Sep; 8(18):1691-8. PubMed ID: 19901516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sesn3 deficiency promotes carcinogen-induced hepatocellular carcinoma via regulation of the hedgehog pathway.
    Liu Y; Kim HG; Dong E; Dong C; Huang M; Liu Y; Liangpunsakul S; Dong XC
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2685-2693. PubMed ID: 31351129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma.
    Cai X; Zhai J; Kaplan DE; Zhang Y; Zhou L; Chen X; Qian G; Zhao Q; Li Y; Gao L; Cong W; Zhu M; Yan Z; Shi L; Wu D; Wei L; Shen F; Wu M
    Hepatology; 2012 Nov; 56(5):1804-16. PubMed ID: 22684921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts.
    Ali N; Allam H; May R; Sureban SM; Bronze MS; Bader T; Umar S; Anant S; Houchen CW
    J Virol; 2011 Dec; 85(23):12292-303. PubMed ID: 21937640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
    Wei Y; Wang Y; Gong J; Rao L; Wu Z; Nie T; Shi D; Zhang L
    Int J Oncol; 2018 Jan; 52(1):219-230. PubMed ID: 29138811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective.
    Chiba T; Kamiya A; Yokosuka O; Iwama A
    Cancer Lett; 2009 Dec; 286(2):145-53. PubMed ID: 19464789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential gene therapy strategies for cancer stem cells.
    Sell S
    Curr Gene Ther; 2006 Oct; 6(5):579-91. PubMed ID: 17073603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.
    Ikeda H; Sato Y; Yoneda N; Harada K; Sasaki M; Kitamura S; Sudo Y; Ooi A; Nakanuma Y
    Hum Pathol; 2012 Nov; 43(11):1955-63. PubMed ID: 22516245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence regarding a stem cell origin of hepatocellular carcinoma.
    Shupe T; Petersen BE
    Stem Cell Rev; 2005; 1(3):261-4. PubMed ID: 17142863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.